Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 3;4(4):ofx213. doi: 10.1093/ofid/ofx213

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — Secondary outcomes. Percentage of patients who experienced unfavorable outcomes pre-procalcitonin (PCT) compared with post-PCT-A implementation. The 30-day readmission rate was calculated by eligible readmissions (eg, # readmissions/(# patients in cohort – # in-hospital deaths)). Adverse drug events during hospitalization from antimicrobials was defined as infusion-related injury or irritation, nausea, vomiting, diarrhea, Q-T interval prolongation, or arthralgia; hospital mortality; or Clostridium difficile infection during hospitalization. Abbreviations: ADE, adverse drug event; CDI, Clostridium difficile infection; PCT, procalcitonin.